Anstey KJ, Peters R. Dementia prevention. NHMRC partnership centre for dealing with cognitive and related functional decline in older people. Sydney: National Health and Medical Research Council (NHMRC); 2019. https://cdpc.sydney.edu.au/research/care-service-pathways/
Ashby-Mitchell K, Burns R, Shaw J, Anstey KJ. Proportion of dementia in Australia explained by common modifiable risk factors. Alzheimers Res Ther 2017;9(1):11. https://www.ncbi.nlm.nih.gov/pubmed/28212674
Coupland CAC, Hill T, Dening T, Morriss R, Moore M, Hippisley-Cox J. Anticholinergic drug exposure and the risk of dementia: A nested case-control study. JAMA Intern Med 2019. https://www.ncbi.nlm.nih.gov/pubmed/31233095
Ding J, Davis-Plourde KL, Sedaghat S, Tully PJ, Wang W, Phillips C, et al. Antihypertensive medications and risk for incident dementia and Alzheimer’s disease: a meta-analysis of individual participant data from prospective cohort studies. Lancet Neurol 2020;19(1):61–70. https://www.ncbi.nlm.nih.gov/pubmed/31706889
Gates NJ, Rutjes AW, Di Nisio M, Karim S, Chong LY, March E, et al. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life. Cochrane Database Syst Rev 2019;3:CD012277. https://www.ncbi.nlm.nih.gov/pubmed/30864187
Gates NJ, Rutjes AW, Di Nisio M, Karim S, Chong LY, March E, et al. Computerised cognitive training for maintaining cognitive function in cognitively healthy people in midlife. Cochrane Database Syst Rev 2019;3:CD012278. https://www.ncbi.nlm.nih.gov/pubmed/30864746
Gates NJ, Vernooij RW, Di Nisio M, Karim S, March E, Martinez G, et al. Computerised cognitive training for preventing dementia in people with mild cognitive impairment. Cochrane Database Syst Rev 2019;3:CD012279. https://www.ncbi.nlm.nih.gov/pubmed/30864747
Hill NT, Mowszowski L, Naismith SL, Chadwick VL, Valenzuela M, Lampit A. Computerized cognitive training in older adults with mild cognitive impairment or dementia: a systematic review and meta-analysis. Am J Psychiatry 2017;174(4):329–40. https://www.ncbi.nlm.nih.gov/pubmed/27838936
Islam MM, Iqbal U, Walther B, Atique S, Dubey NK, Nguyen PA, et al. Benzodiazepine use and risk of dementia in the elderly population: a systematic review and meta-analysis. Neuroepidemiology 2016;47(3-4):181–91. https://www.ncbi.nlm.nih.gov/pubmed/28013304
Jongstra S, Harrison JK, Quinn TJ, Richard E. Antihypertensive withdrawal for the prevention of cognitive decline. Cochrane Database Syst Rev 2016;11:CD011971. https://www.ncbi.nlm.nih.gov/pubmed/27802359
Kane RL, Butler M, Fink HA, Brasure M, Davila H, Desai P, et al. Interventions to prevent age-related cognitive decline, mild cognitive impairment, and clinical Alzheimer's-type dementia [Report 17-EHC008-EF]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2017. https://www.ncbi.nlm.nih.gov/pubmed/28759193
Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396(10248):413–46. https://www.ncbi.nlm.nih.gov/pubmed/32738937
Kivimaki M, Singh-Manoux A, Batty GD, Sabia S, Sommerlad A, Floud S, et al. Association of alcohol-induced loss of consciousness and overall alcohol consumption with risk for dementia. JAMA Netw Open 2020;3(9):e2016084. https://www.ncbi.nlm.nih.gov/pubmed/32902651
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. Lancet 2017;390(10113):2673–734. https://www.ncbi.nlm.nih.gov/pubmed/28735855
McCleery J, Abraham RP, Denton DA, Rutjes AW, Chong LY, Al-Assaf AS, et al. Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment. Cochrane Database Syst Rev 2018;11:CD011905. https://www.ncbi.nlm.nih.gov/pubmed/30383288
McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev 2016;(1):CD003160. https://www.ncbi.nlm.nih.gov/pubmed/26727124
National Institute for Health and Care Excellence (NICE). Dementia: assessment, management and support for people living with dementia and their carers (NG97). London: NICE; 2018. https://www.nice.org.uk/guidance/ng97
National Institute for Health and Care Excellence (NICE). Dementia, disability and frailty in later life-mid-life approaches to delay or prevent onset (NG 16). London: NICE; 2015. https://www.nice.org.uk/guidance/ng16
O’Brien JT, Holmes C, Jones M, Jones R, Livingston G, McKeith I, et al. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology. J Psychopharmacol 2017;31(2):147–68. https://www.ncbi.nlm.nih.gov/pubmed/28103749
Oveisgharan S, Wilson RS, Yu L, Schneider JA, Bennett DA. Association of early-life cognitive enrichment with Alzheimer disease pathological changes and cognitive decline. JAMA Neurol 2020. https://www.ncbi.nlm.nih.gov/pubmed/32597941
Penninkilampi R, Eslick GD. A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias. CNS Drugs 2018;32(6):485–97. https://www.ncbi.nlm.nih.gov/pubmed/29926372
Rabin JS, Klein H, Kirn DR, Schultz AP, Yang HS, Hampton O, et al. Associations of physical activity and beta-amyloid with longitudinal cognition and neurodegeneration in clinically normal older adults. JAMA Neurol 2019. https://www.ncbi.nlm.nih.gov/pubmed/31312836
Richardson K, Fox C, Maidment I, Steel N, Loke YK, Arthur A, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:k1315. https://www.ncbi.nlm.nih.gov/pubmed/29695481
Rutjes AW, Denton DA, Di Nisio M, Chong LY, Abraham RP, Al-Assaf AS, et al. Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life. Cochrane Database Syst Rev 2018;12:CD011906. https://www.ncbi.nlm.nih.gov/pubmed/30556597
Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, et al. Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline. Neurology 2020;95(3):e320–e31. https://www.ncbi.nlm.nih.gov/pubmed/32213642
Sabia S, Fayosse A, Dumurgier J, Dugravot A, Akbaraly T, Britton A, et al. Alcohol consumption and risk of dementia: 23 year follow-up of Whitehall II cohort study. BMJ 2018;362:k2927. https://www.ncbi.nlm.nih.gov/pubmed/30068508
Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, et al. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA 2018;320(7):657–64. https://www.ncbi.nlm.nih.gov/pubmed/30140876
Savolainen-Peltonen H, Rahkola-Soisalo P, Hoti F, Vattulainen P, Gissler M, Ylikorkala O, et al. Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study. BMJ 2019;364:l665. https://www.ncbi.nlm.nih.gov/pubmed/30842086
Shah TM, Weinborn M, Verdile G, Sohrabi HR, Martins RN. Enhancing cognitive functioning in healthly older adults: a systematic review of the clinical significance of commercially available computerized cognitive training in preventing cognitive decline. Neuropsychol Rev 2017;27(1):62–80. https://www.ncbi.nlm.nih.gov/pubmed/28092015
Simons DJ, Boot WR, Charness N, Gathercole SE, Chabris CF, Hambrick DZ, et al. Do “Brain-Training” programs work? Psychol Sci Public Interest 2016;17(3):103–86. https://www.ncbi.nlm.nih.gov/pubmed/27697851
US Preventive Services Task Force (PSTF), Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, et al. Screening for cognitive impairment in older adults: US PSTF recommendation statement. JAMA 2020;323(8):757–63. https://www.ncbi.nlm.nih.gov/pubmed/32096858
Xu W, Tan L, Wang HF, Jiang T, Tan MS, Tan L, et al. Meta-analysis of modifiable risk factors for Alzheimer's disease. J Neurol Neurosurg Psychiatry 2015;86(12):1299–306. https://www.ncbi.nlm.nih.gov/pubmed/26294005
Xu W, Tan CC, Zou JJ, Cao XP, Tan L. Sleep problems and risk of all-cause cognitive decline or dementia: an updated systematic review and meta-analysis. J Neurol Neurosurg Psychiatry 2020;91(3):236–44. https://www.ncbi.nlm.nih.gov/pubmed/31879285
